Field Test for Repellency of Cedarwood Oil and Cedrol to Little Fire Ants

Eastern redcedars (Juniperus virginiana L.) are an abundant renew- able resource and represent a potential source of valuable natural products that may serve as natural biocides. The aromatic wood can be extracted to obtain cedarwood oil (CWO) and critical carbon dioxide (CO2) extraction of eastern redcedars gives both high yields and high quality CWO. In this study, CO2-derived CWO and cedrol, the most abundant component of CWO, were field-tested for repellency against the little fire ant (LFA), Wasmannia auropunctata Roger, in a Hawaiian macadamia orchard. Field tests were conducted using chopsticks baited with peanut-butter placed in established LFA trails on macadamia tree trunks and branches. The chopsticks and any ants present were collected after ca. 24 hours and the number of ants determined by visual counting. Four treatments were compared: Hexane only control; mineral oil; CWO; and cedrol. Control chopsticks and chopsticks treated with mineral oil had very high numbers of ants and were statistically equivalent. The CWO-treated chopsticks had significantly fewer LFAs than all the other treatments. Chopsticks treated with cedrol had fewer ants than the control chopsticks but more than the chopsticks treated with CWO. This research suggests that CWO extracts from J. virginianna may provide a renewable source of a natural ant repellent and could help manage this invasive pest

An apple a day does not keep the weevils away: enhancing vine weevil monitoring with fruit-based volatiles

Vine weevil (Otiorhynchus sulcatus Fabricius; Coleoptera: Curculionidae) is an economically important pest of soft fruit and ornamental crops worldwide. Despite extensive research over three decades, the development of an effective semiochemical lure to improve monitoring for this pest remains a challenge. This study investigated the behavioural and electrophysiological responses of adult vine weevils to apple sauce volatiles under laboratory conditions, using Y-tube olfactometer bioassays and headspace analysis using gas chromatography coupled to mass spectrometry (GC–MS) and GC coupled to electroantennographic detection (GC-EAD). In Y-tube bioassays, more adults selected the olfactometer arm containing apple sauce volatiles compared to the control arm at lower doses (0.1, 1 and 10 g) but not at higher doses (20 g). Thirteen compounds were identified in volatiles collected from apple sauce, with the major components being furfural and sorbic acid. Consistent electrophysiological responses were recorded to (E)-2-heptenal, 1-hexanol, (Z)-3-hexenol and (E)-2-hexenol. The behavioural response of vine weevil adults to refuges baited with semiochemical lures was also tested under glasshouse conditions. In this scenario, a greater proportion of individuals were recorded in refuges baited with apple sauce compared to unbaited refuges. A similar behavioural response was also recorded when refuges were baited with a combination of apple sauce and Fortune's spindle Euonymus fortunei (Turcz.) Hand.-Maz; Celastrales: Celastraceae) compared to those that were unbaited or individually baited with Fortune's spindle or apple sauce. This study indicates that apple sauce positively influences positively vine weevil behaviour and could serve as a basis for developing a novel lure for improved monitoring

ArteFill® Permanent Injectable for Soft Tissue Augmentation: II. Indications and Applications

Patients ask for procedures with long-lasting effects. ArteFill is the first permanent injectable approved in 2006 by the FDA for nasolabial folds. It consists of cleaned microspheres of polymethylmethacrylate (PMMA) suspended in bovine collagen. Over the development period of 20 years most of its side effects have been eliminated to achieve the same safety standard as today’s hyaluronic acid products. A 5-year follow-up study in U.S. clinical trial patients has shown the same wrinkle improvement as seen at 6 months. Long-term follow-up in European Artecoll patients has shown successful wrinkle correction lasting up to 15 years. A wide variety of off-label indications and applications have been developed that help the physician meet the individual needs of his/her patients. Serious complications after ArteFill injections, such as granuloma formation, have not been reported due to the reduction of PMMA microspheres smaller than 20 μm to less than 1% “by the number.” Minor technique-related side effects, however, may occur during the initial learning curve. Patient and physician satisfaction with ArteFill has been shown to be greater than 90%

Transethnic meta-analysis of rare coding variants in PLCG2, ABI3, and TREM2 supports their general contribution to Alzheimer's disease

Rare coding variants in TREM2, PLCG2, and ABI3 were recently associated with the susceptibility to Alzheimer's disease (AD) in Caucasians. Frequencies and AD-associated effects of variants differ across ethnicities. To start filling the gap on AD genetics in South America and assess the impact of these variants across ethnicity, we studied these variants in Argentinian population in association with ancestry. TREM2 (rs143332484 and rs75932628), PLCG2 (rs72824905), and ABI3 (rs616338) were genotyped in 419 AD cases and 486 controls. Meta-analysis with European population was performed. Ancestry was estimated from genome-wide genotyping results. All variants show similar frequencies and odds ratios to those previously reported. Their association with AD reach statistical significance by meta-analysis. Although the Argentinian population is an admixture, variant carriers presented mainly Caucasian ancestry. Rare coding variants in TREM2, PLCG2, and ABI3 also modulate susceptibility to AD in populations from Argentina, and they may have a European heritage.Acknowledgements: This work was supported by grants from the International Society for Neurochemistry (ISN) and Alexander von Humboldt Foundation (to M.C.D.); Agencia Nacional de Promoción Científica y Tecnológica (PBIT/09 2013, PICT-2015-0285 and PICT-2016-4647 to L.M.; PICT-2014-1537 to M.C.D.); GENMED Labex and JPND PERADES grant; and JPND EADB grant (German Federal Ministry of Education and Research, BMBF: 01ED1619A)

Association of kidney disease measures with risk of renal function worsening in patients with type 1 diabetes

Background: Albuminuria has been classically considered a marker of kidney damage progression in diabetic patients and it is routinely assessed to monitor kidney function. However, the role of a mild GFR reduction on the development of stage 653 CKD has been less explored in type 1 diabetes mellitus (T1DM) patients. Aim of the present study was to evaluate the prognostic role of kidney disease measures, namely albuminuria and reduced GFR, on the development of stage 653 CKD in a large cohort of patients affected by T1DM. Methods: A total of 4284 patients affected by T1DM followed-up at 76 diabetes centers participating to the Italian Association of Clinical Diabetologists (Associazione Medici Diabetologi, AMD) initiative constitutes the study population. Urinary albumin excretion (ACR) and estimated GFR (eGFR) were retrieved and analyzed. The incidence of stage 653 CKD (eGFR < 60 mL/min/1.73 m2) or eGFR reduction > 30% from baseline was evaluated. Results: The mean estimated GFR was 98 \ub1 17 mL/min/1.73m2 and the proportion of patients with albuminuria was 15.3% (n = 654) at baseline. About 8% (n = 337) of patients developed one of the two renal endpoints during the 4-year follow-up period. Age, albuminuria (micro or macro) and baseline eGFR < 90 ml/min/m2 were independent risk factors for stage 653 CKD and renal function worsening. When compared to patients with eGFR > 90 ml/min/1.73m2 and normoalbuminuria, those with albuminuria at baseline had a 1.69 greater risk of reaching stage 3 CKD, while patients with mild eGFR reduction (i.e. eGFR between 90 and 60 mL/min/1.73 m2) show a 3.81 greater risk that rose to 8.24 for those patients with albuminuria and mild eGFR reduction at baseline. Conclusions: Albuminuria and eGFR reduction represent independent risk factors for incident stage 653 CKD in T1DM patients. The simultaneous occurrence of reduced eGFR and albuminuria have a synergistic effect on renal function worsening